Leukotriene B4 as a Potential Therapeutic Target for the Treatment of Metabolic Disorders

समान संसाधन

• Leukotriene B4 enhances the generation of pro-inflammatory microRNAs to promote MyD88-dependent macrophage activation
  द्वारा: Wang, Zhuo, और अन्य
  प्रकाशित: (2014)
• Leukotriene B(4)-mediated sterile inflammation favors susceptibility to sepsis in murine type 1 diabetes
  द्वारा: Filgueiras, Luciano Ribeiro, और अन्य
  प्रकाशित: (2015)
• The Role of Leukotrienes as Potential Therapeutic Targets in Allergic Disorders
  द्वारा: Airi Jo-Watanabe, और अन्य
  प्रकाशित: (2019-07-01)
• The Role of Leukotrienes as Potential Therapeutic Targets in Allergic Disorders
  द्वारा: Jo-Watanabe, Airi, और अन्य
  प्रकाशित: (2019)
• Leukotriene B(4) amplifies NF-κB activation in mouse macrophages by reducing SOCS1 inhibition of MyD88 expression
  द्वारा: Serezani, Carlos H., और अन्य
  प्रकाशित: (2011)